Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$1.51 CAD
Change Today -0.04 / -2.58%
Volume 33.2K
NTB On Other Exchanges
As of 3:59 PM 10/8/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

545 Promenade du Centropolis

Suite 100

Laval, QC H7T 0A3


Phone: 450-687-2262

Fax: 450-687-2272

Neptune Technologies & Bioressources Inc., a biotechnology company, engages in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The company produces omega-3 PUFAs through its patented process of extracting oils from Antarctic krill, which omega-3 PUFAs are then principally sold as bulk oil to the company’s distributors who commercialize them under their private labels primarily in the U.S., European and Australian nutraceutical markets. Neptune Krill Oil (NKO) The company’s main product, Neptune Krill Oil, comes in softgel form, serves as a dietary supplement to consumers, and is available at major retailers under distributors’ private labels. NKO is a marine oil extracted from Antarctic krill (Euphasia superba) that contains two omega-3 PUFAs, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and provides a blend of nutritional elements. NKO’s elevated content of phospholipids rich in omega-3 fatty acids and antioxidants, such as astaxanthin, vitamin A and vitamin E offers an effective product free of preservatives. Other Nutraceutical Products ECOKRILL Oil (EKO): EKO, the company’s generic krill oil, is similar to NKO in that it undergoes the same krill oil extraction process. The difference between EKO and NKO is that EKO has lower specifications of omega-3, phospholipids and antioxidants. Rimfrost Oil: This oil has similar specifications and price point as the company’s EKO and is sold as generic krill oil. It is an ethanol based product and sold in some countries where acetone is restricted. New Formulation Derived from NKO: In addition, the company also has developed formulations derived from NKO that target more specific conditions, including NKO Beat, which targets heart and circulation health, NKO Flex, which targets bone and joint health, and NKO Focus, which targets brain and vision health. NKO Beat provides all the heart-healthy Omega-3 EPA and DHA in NKO, plus added ingredients such as Coenzyme Q10 (CoQ10), which is often recommended for heart health support. NKO Flex pairs NKO with other joint and bone health nutrients, such as vitamin D3. Neptune Krill Aquatein (NKA): Neptune Krill Aquatein (krill protein concentrate) is a product that features a range of marine amino acids, including the eight essential amino acids. NKA is being positioned to be sold for animal nutrition. Pharmaceutical Products and Product Candidates – Acasti: The company’s subsidiary, Acasti, focuses on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases. CaPre: CaPre is designed to be used as an adjunctive therapy with positive lifestyle changes and administered either alone or with other treatment regiments, such as statins (a class of drug used to reduce cholesterol levels) and potentially for use by statin-intolerant or statin-resistant patients. CaPre is being developed for the treatment of patients with very high triglycerides with levels over 500 mg/dL (severe hypertriglyceridemia) and eventually for patients with high triglycerides with levels ranging from 200 to 499 mg/dL (mild to moderate hypertriglyceridemia). ONEMIA ONEMIA, a medical commercialized food product, is a purified omega-3 phospholipids concentrate derived from krill oil with lower levels of phospholipids, EPA and DHA content than CaPre. ONEMIA is also available behind-the-counter in some pharmacies. Pharmaceutical Products and Product Candidates - NeuroBioPharm Inc. (NeuroBio) The company’s subsidiary, NeuroBio, is in the early stages of developing omega-3 phospholipids medical foods, over-the-counter products and prescription drugs. NeuroBio is dedicated to the research, development and commercialization of active pharmaceutical ingredients (APIs), for the management of neurodevelopmental, memory, concentration, learning and neurological disorders, from prevention to treatment. NeuroBio addresses mental and neurological conditions, specifically mood disorders such as depression, attention-deficit hyperactivi

Page 12Next Page

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NTB:CN C$1.51 CAD -0.04

NTB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Apator SA 33.50 PLN +0.89
Badger Meter Inc $61.17 USD +1.62
Enzymotec Ltd $9.33 USD -0.34
Itron Inc $35.05 USD +0.86
Targeted Medical Pharma Inc $0.02 USD +0.0011
View Industry Companies

Industry Analysis


Industry Average

Valuation NTB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.0x
Price/Book 2.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEPTUNE TECH & BIORESSOURCES, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at